First Annual Meeting in Leuven

KU Leuven hosted our 1st Annual Meeting at the Faculty Club in Leuven on November 12th and 13th, 2024.

The speakers for each work package provided a comprehensive overview of the project’s activities from the first year. They also engaged in roundtable discussions about research and development activities, upcoming tasks, risks, and mitigation measures.

The meeting was a wonderful opportunity to reconnect in person with the consortium and participate in inspiring and constructive discussions.

Many thanks to the organizers for putting together such a great event!


First Annual Meeting Announced

12-13 November 2024

Faculty Club, Groot Begijnhof 14

Leuven - Belgium


Mention in Nature Biotechnology's paper

InnovationActa

The B-specific consortium is proud to be mentioned in a recent paper in Nature Biotechnology entitled “The European Innovation Council supports innovative portfolios in health biotech”  LINK to paper and we would like to thank Iordanis Arzimanoglou for his work.

The European Innovation Council (EIC) was officially launched in March 2021 with the aim of creating an ecosystem that promotes deep-tech, science-based businesses by leveraging European research and development initiatives and unlocking Europe’s innovative potential. B-specific is participating in the EIC Cardiogenomics Challenge, which seeks to enhance the correlation between the well-established pathology of heart disease and various biomarkers.

The EIC Cardiogenomics portfolio is designed to offer valuable, interdisciplinary insights into how known and newly identified polymorphisms contribute to the susceptibility, onset, and progression of various forms of cardiovascular disease.

Here you can find the link: to open access version of the paper


ABC research presented at the Imperial Vulnerable Plaque and Patient 2024 meeting

InnovationActa

On the 23rd of September, Amanda Foks was invited to present her research findings on age-associated immunity, including ABCs, in atherosclerosis, online at the Imperial Vulnerable Plaque and Patient meeting (VPM2024), which took place at Sevilla, Spain. The meeting was broadcasted online.


Best poster presentation award for Jill de Mol at the GEMseq 2024 meeting

InnovationActa

During the 6th edition of the Graz Expert Meeting on Single-cell sequencing technologies in the cardiovascular field, held on September 15 and 16 in Graz, Austria, Jill de Mol from the group of Amanda Foks from Leiden University received the award for best poster presentation.

During this annual symposium, organized at the Medical University of Graz, basic scientists and clinicians were invited to present and discuss their recent advances with single cell sequencing technologies in the field of atherosclerosis. Amanda was invited to present her work on ‘Single cell profiling of age-associated immunity in atherosclerosis’. During the poster session, Jill de Mol presented her work on age-associated B cells as pro-atherogenic drivers in murine atherosclerosis and their association with human coronary events.


COSTaction network AtheroNET

InnovationActa

On September 15th 2024  Assoc. Prof. Bram Slütter (ULEI) provided an online seminar, entitled ‘Resident memory cells in atherosclerosis’ for the COSTaction network AtheroNET


Webinar European Society of Cardiology

InnovationActa

During an online webinar on inflammation in atherosclerosis, organized by the European Society of Cardiology, Ilze Bot lectured on the use and application of single-cell RNA sequencing in atherosclerosis. She specifically discussed two cases where such data can be of interest in target discovery and for mechanistic insight, also related to B cells.


ESC Congress 2024

InnovationActa

Prof. Maryam Kavousi (EMC) participated at the congress of the European Society of Cardiology (ESC Congress 2024) held in London between 30th  August and 2nd September 2024.

Prof. Kavousi gave the two following talks
Do genetic scores help risk stratify in primary prevention?
LINK to slides
Prevention: personalising cardiovascular prevention
LINK to slides
The slides can be accessed via the links after sign in


Webinar European Vascular Biology Meeting

InnovationActa

On June 18, Ilze Bot participated in the monthly webinar organized by the European Vascular Biology Meeting. She presented her work on mast cells in cardiovascular disease, also referring to antibodies and antigens that may activate these cells, in relation to the B-specific work.


KUL team participation at conferences in May -June 2024

InnovationActa

American Society of Gene & Cell Therapy

Nick Geukens from the KUL team took part in the American Society of Gene & Cell Therapy 27th Annual Meeting held between 7th and 11th May 2024 in Baltimore, United States
The KUL team presented their work related to unraveling the multifactorial host immune response triggered by intramuscular electrotransfer of a DNA-encoded antibody.

Biotech conference in the Benelux

Members of the KUL team joined in the biggest biotech conference in the BeNeLux, Knowledge for Growth, held between 15th and 16th May 2024 in Antwerpen, Belgium.

“Antigen-Specific Immune Monitoring of T Cells, B Cells, and Non-conventional Immune Cells” Conference

On the 12th of June 2024, Nick Geukens from the KUL team participated in the conference dedicated to “Antigen-Specific Immune Monitoring of T Cells, B Cells, and Nonconventional Immune Cells”. The event was held in Amsterdam, Netherlands.

To view more

American Society of Gene & Cell Therapy
Baltimore – United States
go to the website: https://annualmeeting.asgct.org/

Biotech conference in the BeNeLux
Antwerpen – Belgium
go to the website: https://knowledgeforgrowth.be/

“Antigen-Specific Immune Monitoring of T Cells, B Cells, and Non-conventional Immune Cells” Conference
Amsterdam, Netherlands.
go to the website: https://www.immudex.com/